Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Jul
9
2014
And Speaking of Foreign Trademark Filing Strategy: Tesla Motors is Sued in China for Trademark Infringement Mintz
Aug
20
2020
Danger on the Horizon: Detecting Early Signs of Trade Secret Theft by Competitors Mintz
Aug
7
2014
Copyright Ownership is not Monkey Business: Wikimedia and Slater Fight Over Selfie Photographs Mintz
Sep
15
2020
Fact-Specific Inquiry: Deciding Between Trade Secret and Patent Protection Mintz
Nov
9
2020
Tip #4 for Avoiding IPR Institution: Don’t Argue Facts Mintz
Feb
9
2021
Federal Circuit Says Automated Systems Are Not Abstract when Tied to Improvements Mintz
Feb
17
2021
Copy Cats II: Nexus of Copying Required to Substantiate Non-Obviousness Mintz
Mar
31
2021
Best Practices for Clearances and Opinions Mintz
Nov
24
2014
ALJ Lord Amends Ground Rules to Permit Reply Briefs Mintz
Apr
22
2021
Patent Owner Tip #3 for Surviving An Instituted IPR: How Patent Owner Experts Go from Zero to Hero Mintz
Dec
10
2014
Federal Circuit Finds Patent Claiming Software-Related Invention is Patentable Mintz
Jun
24
2021
Arthrex: PTAB Lives to Fight Another Day with (a Bit) More Oversight [PODCAST] Mintz
Sep
9
2021
Federal Circuit Reiterates Requirement under § 287 that Alleged Infringers have Notice of Specific Alleged Infringement Mintz
Oct
6
2021
Invalidity of Terminal Patents Not Tied to Disclaimed Patent-in-Suit’s Expiration Mintz
Mar
24
2015
USITC Declines to Institute Investigation of Induced Patent Infringement as Unfair Method of Competition or Unfair Acts Mintz
Dec
8
2021
Quentin Tarantino’s Secret NFTs Mintz
May
1
2015
Petitioners Must Present Sufficient Evidence to Establish Inherency Mintz
Feb
17
2022
D. Del. Says ANDA Specification Trumps All Else in Infringement Analysis Mintz
Sep
25
2017
DTSA Does Not Create a Private Civil Cause of Action for Conspiracy to Commit Trade Secret Theft Mintz
Dec
12
2017
SAS v. Matal – Overview of Oral Argument Mintz
Mar
21
2012
Applying for a New gTLD? Registration Deadline of March 29, 2012 Approaches As Cybersquatting Continues To Rise. Mintz
Jul
22
2022
Judge Albright Holds Willful Infringement Pleading Does Not Require Allegations of Egregious Infringing Behavior Mintz
Aug
1
2022
Lost Profits – Who’s Sale is it Anyway? Mintz
Aug
11
2015
Suprema v. ITC: En Banc Federal Circuit Overturns Panel Decision, Finds ITC Has Jurisdiction OverInduced Infringement of Method Claims Mintz
Oct
10
2022
An Emerging Split on the Applicability of the Inevitable Disclosure Doctrine Under the DTSA Mintz
Jun
22
2018
With its Vanda Pharma and Berkheimer memos, USPTO provides increased clarity around personalized medicine patent eligibility Mintz
Aug
15
2018
Google’s Servers Housed By A Third-Party ISP Qualify As A Regular And Established Place Of Business To Establish Proper Venue In The Eastern District Of Texas Mintz
Nov
5
2015
FTC Urges FDA to Rethink Biosimilar Naming Proposal; Other Stakeholders Agree Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins